FindTrial
Sign In

Role of Probiotic Supplements in the treatment of Tuberculosis patients

Probiotic Supplementation in Patients with Pulmonary Tuberculosis: A Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039335
Enrollment
208
Registered
2022-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

None listed

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed Pulmonary Tuberculosis patients

Exclusion criteria

Exclusion criteria: incomplete case records, Patients who missed a follow-up, resistant tuberculosis patients

Design outcomes

Primary

MeasureTime frame
Both the cohort group will be compared for sputum conversion and reversion rate, treatment outcome, Routine laboratory tests, ATT induced side effects, nutritional parameters.Timepoint: Three Time Points- At Baseline, after 2 months, after 6 months—

Secondary

MeasureTime frame
HRQoL and medication adherence measures will be compared in both the cohorts.Timepoint: Three Time Points- At Baseline, after 2 months, after 6 months—

Countries

India

Contacts

Public ContactTejaswini Baral

Manipal College of Pharmaceutical Sciences

sonal.sekhar@manipal.edu917411338846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026